You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 28, 2017

Indonesia Implementing Halal Assurance System

Subscribe to Updates
Informed Counsel

The private sector in Indonesia has been vocal about their concern for the government’s plan to make halal certification mandatory, believing that this requirement will add a greater burden to their business. Amid criticism, the government is moving forward with its halal assurance system, citing, among other reasons, the need for a government agency to be the new halal certification authority to create greater transparency in the existing certification process.

Halal Regulators

Halal certificates can currently be obtained from the Islamic Council (MUI), which is an autonomous organization not belonging to the government. With the introduction of the new Indonesian halal assurance system earlier this year, the Halal Product Assurance Organizing Agency (BPJPH) was inaugurated by the Ministry of Religious Affairs on October 11, 2017, to take over the MUI’s main halal certification duties and is expected to start operations by 2018.

The BPJPH has the authority to issue and revoke the halal certificate and halal label on products, carry out administration of halal certification of domestic and foreign products, supervise the guarantee of halal products, work with halal inspection agencies (LPH) on product inspection and/or testing, and conduct public relations campaigns to inform the public about halal products.

Once the BPJPH commences operations, the MUI will continue to play a role in the halal certification process by providing religious decrees to determine the halal status of a product. MUI decrees must be submitted to the BPJPH as the basis for the issuance of a halal certificate. Additionally, the MUI will work with the BPJPH in certification of halal auditors and accreditation of LPHs.

Transitional Period

Two draft halal regulations—one covering governmental fees and the other covering implementation and guidelines of the halal assurance system—have been prepared and are being reviewed by the Ministry of Finance and the Ministry of Laws and Human Rights. Until the two laws enter into force, halal certificates will be issued by the MUI. After the laws take effect, halal certificates that have been issued by the MUI will remain valid until the date indicated on the certificate, with the next renewal of such certificates to be filed with the BPJPH.

Currently, each halal certificate that has been issued by the MUI is valid for two years. Later, upon the transfer to the BPJPH, the validity period of each certificate will be four years with the possibility of renewal.

The Indonesian government has imposed a deadline of October 17, 2019, for all required products to be halal-certified. However, there is a grace period of three years for food and beverage products, and a grace period of five years for cosmetics and drugs. It is important to note that life-saving medicines which have no substitutes are likely to be exempted from the halal-certificate obligation.

Products That Require Halal Certification

Although an exhaustive list is not yet available, the types of products that generally must be halal-certified include food, beverages, medicinal products, cosmetics, chemical products, biological products, and genetically engineered products.

To obtain halal status, both product materials and manufacturing processes will be inspected. Each company must have an in-house supervisor set up a halal assurance system and conduct periodic inspections to maintain the system. Products that contain non-halal substances or are non-halal because of their manufacturing process can still be sold in Indonesia but must be labeled “non-halal.”

Imported Products

Indonesia’s National Agency of Drug and Food Control (BPOM) currently requires products that will be imported, distributed, and traded in Indonesia to have an MUI halal certificate if the applicant wishes to include halal information/logo on their product label. In the future, this requirement will not be necessary if the product has been certified by the halal certification agency in its country of origin.

The BPJPH, the Ministry of Religious Affairs, and the Ministry of Foreign Affairs are collaborating on drafting an intergovernmental cooperation agreement for Indonesia and other nations. This bilateral agreement will enable certificates issued by a halal certification agency in one country to be recognized in Indonesia, and, once in effect, applicants will only be required to register their halal logo with the BPJPH with no additional certification actions needed.

Indonesia’s new halal assurance system may appear complicated. However, the government is expending considerable effort in simplifying procedures and requirements, and setting costs that are affordable for all. With the establishment of the BPJPH and the drafting of halal assurance laws, it is anticipated that the halal assurance system in Indonesia will soon be more efficient than ever before.

Download Full Article
Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

July 24, 2026
As food innovation continues to accelerate, manufacturers are increasingly introducing ingredients derived from new sources, produced using novel technologies, or lacking a significant history of human consumption. While these innovations create new opportunities for the food industry, they also raise important questions regarding consumer safety. For this reason, many jurisdictions, including Thailand, the European Union, Australia and New Zealand, Canada, and Singapore, require a premarket safety assessment for novel food ingredients before they can be placed on the market. The objective of this assessment is to ensure that each ingredient is safe for its intended use and level of consumption, does not present toxicological, allergenic, microbiological, or nutritional concerns, and will not mislead consumers. Scientific authorities typically evaluate the ingredient’s identity, manufacturing process, composition, specifications, anticipated dietary exposure, toxicological information, nutritional impact, and history of use before determining whether it can be marketed. Against this background, the Thai Food and Drug Administration (FDA) recently took an important step toward improving regulatory transparency by publishing, for the first time, a consolidated public list of substances that have successfully completed the Thai FDA’s safety assessment process, including substances determined to be novel foods and those determined not to fall within the novel food category. The list identifies the approved substances, the corresponding manufacturers or importers, approval dates, and the approved conditions of use. Although the publication does not change the existing legal framework governing novel food approvals, it provides businesses with greater visibility into the Thai FDA’s regulatory precedents and the types of substances that have previously been accepted through the safety assessment process. The full announcement is available on the Thai FDA’s website. As the list is now publicly available, it also provides useful insight into the types of substances that have successfully completed the Thai FDA’s safety assessment process.
Read More
July 24, 2026
For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers. To legally do this, a business may need approvals from several different agencies—separate permits for the chicken (Department of Livestock Development), the dipping sauce (Thai FDA), the wooden skewers (Department of Forestry), and other ingredients, each under a different authority. This kind of overlap is often cited to argue for a “regulatory guillotine”—a systematic review to cut outdated or duplicative rules that slow investment and business activity. The Facilitation of Licensing and Public Service Consideration Act B.E. 2569 (2026) (Licensing Facilitation Act 2026) is Thailand’s most significant response yet to that concern. This article looks at the Facilitation Act 2026 through a life sciences and regulatory affairs lens—what it may mean for the manufacturers, importers, and distributors of food, drugs, medical devices, cosmetics, and similar products who routinely deal with several regulators to bring a single product to market. The Super License: One Approval Standing in for Many The reform with the clearest potential for regulated-product businesses is the law’s “super license” mechanism, referred to as a “main license” in the statute. Once a business obtains the main license for a regulated activity, it is automatically deemed to hold all related sublicenses issued by other agencies for that same activity, provided the activity has been designated as eligible in the Government Gazette. The Licensing Facilitation Act 2026 also creates a central application center, allowing applicants to submit a single application and pay all relevant fees at one point of contact, with the center routing the application to each agency through a shared information system. The potential benefits of this for businesses
Read More
July 13, 2026
Indonesia’s Halal Product Assurance Agency (BPJPH) has issued new regulations establishing clearer procedures for imposing administrative sanctions on businesses that violate halal product assurance requirements. BPJPH Regulation No. 2 of 2026 on the Imposition of Administrative Sanctions for Violations of Halal Product Assurance Implementation, issued on June 5, 2026, strengthens Indonesia’s halal compliance framework, as mandated under Law No. 33 of 2014 on Halal Product Assurance and Government Regulation No. 42 of 2024 on the Implementation of Halal Product Assurance. BPJPH Regulation No. 2/2026 also supports the upcoming mandatory halal compliance deadline of October 17, 2026, which will apply to a broad range of products and services, including imported food and beverages, slaughtering products and services, natural and quasi-drugs, health supplements, cosmetics, chemical and genetically engineered products, clothing and accessories, household goods, prayer equipment, stationery, and class A medical devices. Scope BPJPH is authorized to impose administrative sanctions for violations of halal product assurance requirements committed by businesses, halal inspection agencies (LPH), halal auditors, halal product process companion institutions (lembaga pendamping PPH), and halal product process companions (pendamping PPH). The head of BPJPH has authority to determine, cancel, or amend the imposition of administrative sanctions, including upon receipt of objections. This authority covers revocation of Halal Certificates (including foreign halal certificate registration numbers), withdrawal of goods from circulation, freezing of LPH operations, freezing of halal product process companion institutions, revocation of PPH companion institution registration numbers, revocation of halal auditor registration numbers, and revocation of LPH accreditation status. Administrative Sanctions Businesses may be subject to any of the following administrative sanctions: Written warning; Administrative fine; Revocation of the halal certificate, including revocation of foreign halal certificate registration numbers; and Withdrawal of goods from circulation. The regulation sets out the types of violations that may trigger these sanctions, with each
Read More
July 1, 2026
Obtaining marketing authorization is a fundamental requirement for bringing pharmaceutical products to the Thai market. Companies must navigate the Thai Food and Drug Administration’s registration procedures while also complying with post-approval pharmacovigilance obligations, licensing requirements for manufacturing and importation, data protection rules, and other regulatory requirements. This guide provides an overview of Thailand’s regulatory framework for pharmaceutical marketing authorization, including available registration pathways, review timelines, application fees, postmarketing surveillance obligations, licensing requirements, exemptions, data exclusivity, freedom of information, and parallel import considerations. It is intended as a practical reference for pharmaceutical companies, regulatory affairs professionals, and others involved in bringing medicinal products to the Thai market. Download the guide below for a concise overview of the current requirements and procedures governing pharmaceutical marketing authorization in Thailand.
Read More